Pulmatrix Inc
(NASDAQ : PULM)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
-1.65%88.151.3%$855.06m
AMGNAmgen Inc.
-2.71%186.701.2%$536.92m
BIIBBiogen Inc.
-4.48%216.711.3%$511.45m
ONCESpark Therapeutics, Inc.
-0.24%113.0011.2%$460.68m
GILDGilead Sciences, Inc.
-1.77%63.770.9%$455.57m
REGNRegeneron Pharmaceuticals, Inc.
-2.68%391.802.6%$275.42m
ILMNIllumina, Inc.
-3.26%308.793.5%$273.28m
VRTXVertex Pharmaceuticals Incorporated
-0.56%181.531.9%$235.95m
BPTHBio-Path Holdings, Inc.
18.94%21.98190.1%$220.64m
SRPTSarepta Therapeutics, Inc.
-3.47%122.2615.4%$207.36m
EXASExact Sciences Corporation
-3.28%89.0025.3%$185.14m
ALXNAlexion Pharmaceuticals, Inc.
-2.98%130.212.0%$179.59m
AAgilent Technologies, Inc.
-3.68%78.981.6%$135.89m
IONSIonis Pharmaceuticals, Inc.
-1.99%78.908.3%$104.26m
INCYIncyte Corporation
-2.00%85.342.5%$93.76m

Company Profile

Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the discovery and development of novel inhaled therapeutic products. The firm focuses on the prevention and treatment of respiratory diseases and infections. It offers products based on its proprietary dry powder delivery technology, iSPERSE, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov and Robert S. Langer, Jr. on June 15, 2015 and is headquartered in Lexington, MA.